Replies to post #29982 on Intellipharmaceutics International Inc. (IPCI)

[AngeloFoca]

Thanks Angelo, I needed a message like yours

I know... you and many others here... even Doog had gone to the "dark side" a few days ago.

We all know this as truth:

IPCI will be cash flow positive on Seroquel XR alone... and there is nothing the shorts can do about it... and on top of that, Focalin will bring in approximately $5 million in 2018... and there is nothing the shorts can do about it... we don't know when, but Lamictal and Pristiq with a combined market of $1.3 BILLION which are already partnered with MNK and can go straight to rollout are bound to be approved, they can easily bring in $20 million to IPCI's bottom line... and there is nothing the shorts can do about it... IPCI has a better product than Pfizer's Lyrica... a $4.2 BILLION drug going off patent end of 2018... and there is nothing the shorts can do about it... and on top of that is PODRAS, Rexista and 4 drug delivery platforms other than PODDS which IPCI has not even scratched the surface on due to lack of funds and manpower... which I think will change soon... and there is nothing the shorts can do about it... there are 2.9 million shares short and if IPCI can weather this rough patch without doing a poisoned PP, then the only thing shorts can do about it is to COVER.